Results 11 to 20 of about 120,700 (216)

Complications After Deep Brain Stimulation: A 21-Year Experience in 426 Patients

open access: yesFrontiers in Aging Neuroscience, 2022
BackgroundDeep brain stimulation is an established treatment for movement disorders such as Parkinson’s disease, essential tremor, and dystonia. However, various complications that occur after deep brain stimulation are a major concern for patients and ...
In-Ho Jung   +6 more
doaj   +1 more source

Adaptive Deep Brain Stimulation for sleep stage targeting in Parkinson’s disease

open access: yesBrain Stimulation, 2023
Background: Sleep dysfunction is disabling in people with Parkinson’s disease and is linked to worse motor and non-motor outcomes. Sleep-specific adaptive Deep Brain Stimulation has the potential to target pathophysiologies of sleep.
Clay Smyth   +5 more
doaj   +1 more source

Functional imaging of deep brain stimulation in dystonia: a review

open access: yesDystonia, 2023
Much remains to be learned about the mechanism of benefit of deep brain stimulation in movement disorders in general and dystonia specifically. A full accounting of the pathophysiology of dystonia additionally remains unclear.
Ian O. Bledsoe, Melanie A. Morrison
doaj   +1 more source

Deep brain stimulation for obsessive compulsive disorder leads to symptom changes of comorbid irritable bowel syndrome

open access: yesFrontiers in Psychiatry
IntroductionIrritable bowel syndrome (IBS) is a common condition characterized by abdominal pain and altered bowel habits, affecting around 11% of individuals globally.
Mohamed A. Abdelnaim   +9 more
doaj   +1 more source

Deep brain stimulation of the nucleus accumbens core but not shell reduces motivational components of heroin taking and seeking in rats

open access: yesBrain and Neuroscience Advances, 2017
Background: Deep brain stimulation is explored as a new intervention for treatment-resistant substance use dependence. A candidate brain region is the nucleus accumbens, due to its involvement in reward and motivation. This study aimed to explore effects
Maria C. Schippers   +7 more
doaj   +1 more source

The quest for a target and the beginning of the DBS-story

open access: yesDeep Brain Stimulation
Deep brain stimulation (DBS) of the subthalamic nucleus (STN) has revolutionized the treatment of Parkinson’s disease. It is considered as a treatment of choice, after Levodopa, for patients suffering from advanced stages of the disease.
Abdelhamid Benazzouz
doaj   +1 more source

The Oscillatory Profile Induced by the Anxiogenic Drug FG-7142 in the Amygdala–Hippocampal Network Is Reversed by Infralimbic Deep Brain Stimulation: Relevance for Mood Disorders

open access: yesBiomedicines, 2021
Anxiety and depression exhibit high comorbidity and share the alteration of the amygdala–hippocampal–prefrontal network, playing different roles in the ventral and dorsal hippocampi.
Hanna Vila-Merkle   +8 more
doaj   +1 more source

Neurophysiology in deep brain stimulation: Bridging clinical practice and systems neuroscience

open access: yesDeep Brain Stimulation
As understanding of neurophysiology has progressed from individual neurons to large-scale brain networks, deep brain stimulation (DBS) has been established as a major intervention for neurological and psychiatric diseases. Here we review (1) the clinical
Julie Lewentz   +2 more
doaj   +1 more source

Transferrin receptor 1‐mediated iron uptake supports thermogenic activation in human cervical‐derived adipocytes

open access: yesFEBS Letters, EarlyView.
In this study, we found that human cervical‐derived adipocytes maintain intracellular iron level by regulating the expression of iron transport‐related proteins during adrenergic stimulation. Melanotransferrin is predicted to interact with transferrin receptor 1 based on in silico analysis.
Rahaf Alrifai   +9 more
wiley   +1 more source

Targeting pain with deep brain stimulation: Insights into the thalamus and associated structures

open access: yesDeep Brain Stimulation
Chronic pain is a major public health issue, and despite advances in understanding its pathophysiology, current treatments remain insufficient, significantly affecting patients' quality of life.
Rabia Bouali-Benazzouz   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy